OssDsign extends the Catalyst portfolio and launches new product for additional surgical procedures
Uppsala, 3 November 2022. OssDsign AB (publ.) announces today that the company is launching a new size of OssDsign Catalyst. The additional volume option of 1 cubic centimetre (cc) completes the existing product range of 10, 5 and 2,5 ccs, and broadens the access to new procedures in both cervical spine and smaller extremities. The product is expected to launch in the first quarter of 2023.The addition of the 1cc option completes the size range of OssDsign Catalyst, giving the company competitive strength in hospital approval processes and allowing for deeper usage in already approved